ES
MARKETS / NASDAQ / OMDA
NASDAQ · SERVICES-HEALTH SERVICES

Omada Health, Inc. OMDA

3 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$260.2M
▲ 53.2% vs FY2024
EPS · FY25
$-0.35
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-4.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 260.2M
Revenue, FY2025 · full 3-year series below
Revenue Net income
0.080.160.240.320.3-0.020232025
0.080.160.240.320.3-0.020232025

The company lost 5 cents on every revenue dollar this year.

Per share
USD -0.35
Diluted EPS, FY2025
EPS
0.40.81.2-0.3520232025
0.40.81.2-0.3520232025

The company pays no cash dividend.

Profitability
—
Return on equity, FY2025
ROE
0.250.50.75120232025
0.250.50.75120232025
Operating margin-4.6%
Net margin-4.9%
Return on assets-5.6%

Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—

Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.06B
Shares outstanding, FY2025
0.010.0620232025
0.010.0620232025
Change, 5 years—
Change, 10 years—

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 305.4M
total assets, end of FY2025
Total assetsUSD 305.4M
EquityUSD 229.7M
CashUSD 222.0M
Gross debtUSD 0.00
Net debtUSD -222.0M
Current ratio3.60×

The company holds more cash than debt.

History
3 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
Revenue $B
0.3
0.2
0.1
Operating income $B
−0.0
−0.0
−0.1
EBITDA $B
−0.0
−0.0
−0.1
Income tax $B
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.1
EPS, diluted $
−0.35
−6.11
−9.52
Dividend / sh $
·
·
·
Payout %
·
·
·
ROE %
·
·
·
Shares out B
0.06
0.01
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
10 of 10
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed